Chemicals and Materials Sterile Packaging Market New

The report "Regulatory Environment and Impact Analysis- Sterile Packaging Market
Standards & Regulations, Regional & National Regulatory Bodies - Market Analysis &
Forecast to 2020", The market for sterile medical packaging is projected to grow from
USD 26.55 Billion in 2015 to USD 35.07 Billion by 2020, at an estimated CAGR of 5.72%.
Browse 33 market data Tables and 39 Figures spread through 121 Pages and in-depth TOC on
"Regulatory Environment and Impact Analysis - Sterile Packaging Market"
https://www.marketsandmarkets.com/Market-Reports/regulatory-environment-impact-
analysis-sterile-packaging-market-133232063.html
Early buyers will receive 10% customization on this report.
North America dominated the Market for Sterile Medical Packaging in 2014 and has
the most organized regulatory framework for sterile medical packaging
On the basis of key regions, the Market for Sterile Medical Packaging is segmented into
North America, Europe, Asia-Pacific, and Rest of the World (RoW). The North American
region held the largest share among all the regions in 2014. This is mainly due to rising
healthcare awareness and continuous innovation & technological developments in both
pharmaceutical & medical industries which are transforming the healthcare packaging
industry further, thereby driving the growth of the sterile medical packaging market.
Further, the regulatory framework in North America is organized, effective, strong, and
transparent. Factors such as timelines for the medical device approval process, cost for
placing the product in the market, and ease of doing business have been considered for
defining the structure of the sterile medical device regulatory framework. Countries such
as the U.S., Canada, and Mexico have been considered for the study. In North America, the
regulations implemented by governing bodies such as U.S. FDA and ASTM have been
followed as international standards and regulations by different countries across the
region. While in Asia-Pacific, factors such as longer timelines for approving the medical
devices in Australia, red tapism in India, and higher cost for approval of the medical device